bcbs glp 1 Blue Cross Blue Shield plans reverse course on GLP-1 coverage Life - New Year, New
Description
But while these medications are game-changers, what you eat still matters a lot.
Unlike semaglutide, which focuses primarily on GLP-1 receptor activation to manage blood sugar and appetite, Personalized GLP-1targets additional metabolic pathways for a more comprehensive weight management solution

But what do we need to consider when using them in older age

Expert guidance on keeping weight off and achieving long-term GLP-1 success.

Physiological Effects Semaglutide exerts its therapeutic benefits through multiple complementary mechanisms: Enhanced Insulin Secretion: Stimulates glucose-dependent insulin release from pancreatic beta cells, improving postprandial glucose control[3][4] Glucagon Suppression: Inhibits glucagon release, reducing hepatic glucose production and improving fasting blood glucose levels[3][4] Delayed Gastric Emptying: Slows the movement of food from the stomach to the small intestine, reducing postprandial glucose excursions and promoting satiety[4][5] Appetite Reduction: Directly affects the central nervous system to decrease food intake and energy consumption[4][5] Improved Metabolic Flexibility: Enhances the body's ability to switch between energy substrates based on availability[2] At the cellular level, semaglutide primarily operates through the AMPK (AMP-activated protein kinase) pathway, which regulates cellular energy homeostasis and improves insulin sensitivity

Meanwhile, Eli Lilly is advancing orforglipron, the first small-molecule GLP-1 receptor agonist for obesity